close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Hantavirus outbreak isn't another Covid pandemic – but experts say it's testing U.S. readiness
Tags Novo Nordisk A/S Health & Science Social issues
From CNBC.com News
Inside India newsletter: Trump-Xi meeting could test India’s positioning as China counterweight
Tickers RH
Tags Morgan Stanley Social media Meta Platforms Inc
From CNBC.com News
Healthy Returns: Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight
Tags Social issues Eli Lilly and Co Health care industry
From CNBC.com News
Hims & Hers plummets 16% after first-quarter loss, weak earnings guidance
Tags Business News Europe News U/S/ Markets
From CNBC.com News
Asia's trillion-dollar titans are powering — and distorting — its fastest growing stock markets
Tags Stock markets Asia/Pacific Homepage iShares MSCI Taiwan ETF
From CNBC.com News
Global week ahead: Crude diplomacy casts shadow over Trump-Xi summit
Tags Global Week Ahead iShares MSCI France ETF iShares 20+ Year Treasury Bond ETF
From CNBC.com News
CNBC Daily Open: Leadership challenge swirls around Starmer
Tags Microsoft Corp Europe Markets Strategy Inc
From CNBC.com News
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk
Tags Health care industry Novo Nordisk A/S Health & Science
From CNBC.com News
CNBC Daily Open: Iran reviews 'one-page peace plan'
Tags World Markets Alphabet Class A Pinterest Inc
From CNBC.com News
Inside India newsletter: Social media is reshaping the world's fastest-growing market for global brands
Tickers RH
Tags Novo Nordisk A/S World News Coca/Cola Co
From CNBC.com News
Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals
Tags Biotech and Pharmaceuticals Health & Science Novo Nordisk A/S
From CNBC.com News
Wegovy sales smash forecasts after pill launch as Novo Nordisk hikes guidance
Tags Biotech and Pharmaceuticals Earnings Novo Nordisk A/S
From CNBC.com News
European stocks set to rise as oil prices fall after Trump signals Iran war de-escalation
Tags Europe Markets World Economy World Markets
From CNBC.com News
CNBC Daily Open: Kospi bull run rolls on
Tags Strategy Inc Meta Platforms Inc Europe Markets
From CNBC.com News
Iran tensions, Palantir earnings, Musk's SEC settlement and more in Morning Squawk
Tags Elevance Health Inc American Eagle Outfitters Inc United Parcel Service Inc
From CNBC.com News
Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly's GLP-1 dominance
Tags Eli Lilly and Co Health & Science Novo Nordisk A/S
From CNBC.com News
'Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds
Tags Business News iShares Biotechnology ETF Eli Lilly and Co
From CNBC.com News
CNBC Daily Open: As Gulf fatigue sets in, earnings take center stage
Tags Markets HSBC Holdings PLC UniCredit SpA
From CNBC.com News
Global week ahead: Is 'Sell in May' just a myth?
Tags Commerzbank AG iShares MSCI France ETF iShares 20+ Year Treasury Bond ETF
From CNBC.com News
Weight loss and hair loss: The growing hair treatment market from GLP-1s
Tags Retail L'Oreal SA Ulta Beauty Inc
From CNBC.com News
Apple earnings, DHS shutdown, 'Ozempic breath' and more in Morning Squawk
Tags Berkshire Hathaway Inc iPhone Investing
From CNBC.com News
Healthy Returns: Eli Lilly’s chief scientific officer breaks down the latest obesity pill data
Tags Biotech and Pharmaceuticals Healthy Returns Health care industry
From CNBC.com News
Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval
Tags Biotechnology Health & Science Novo Nordisk A/S
From CNBC.com News
A world on weight loss drugs: How GLP-1s are reshaping the economy
Tags Zealand Pharma A/S Roche Holding AG Travel
From CNBC.com News
Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors
Tags CVS Health Corp Health & Science Roche Holding AG
From CNBC.com News
FDA approves first-ever glucose monitoring system for weight loss from Signos
Tags Health & Science Novo Nordisk A/S Biotechnology
From CNBC.com News
Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data
Tags US: News Biotech and Pharmaceuticals Companies
From CNBC.com News
Home Depot disappoints, Novo Nordisk's GLP-1 updates, an AI warning and more in Morning Squawk
Tags Intel Corp Business Investment strategy
From CNBC.com News
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
Tags US: News Biotech and Pharmaceuticals Companies
From CNBC.com News
5 things to know before the Thursday open: Chip tariffs | Cook's White House visit | Wall Street's fashionista
Tags Investing Novo Nordisk A/S Economy
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.